TP53 and hepatocellular carcinoma: Shen et al. have revealed that HCC patients with a high expression of RING1 have a poor prognosis, while depletion of RING1 can inhibit the proliferation of wild-type p53 cells via cell-cycle arrest and induce apoptosis19.